BioSpace News Archive

Press Releases

United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026

April 20, 2026
·
6 min read
Press Releases

Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference

April 20, 2026
·
7 min read
Press Releases

Asahi Kasei Announces Initiation of Phase I Clinical Trial for Novel Peptide Candidate Targeting Autoimmune Diseases

April 20, 2026
·
2 min read
Press Releases

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

April 20, 2026
·
4 min read
Press Releases

Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering

April 20, 2026
·
5 min read
Press Releases

Immunofoco Presents Preclinical Data for IMV102, an In Vivo CAR-T Candidate, Demonstrating Durable Tumor Control at the AACR 2026

April 20, 2026
·
3 min read
Press Releases

Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026

April 20, 2026
·
3 min read
Press Releases

FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer

April 20, 2026
·
19 min read
Press Releases

Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1)

April 20, 2026
·
4 min read
Press Releases

Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer

April 20, 2026
·
7 min read